Individuals Stopping Slimming Jabs Regain Weight Far More Rapidly Compared to Dieters

New research indicates that people who stop using blockbuster slimming jabs like Mounjaro or Wegovy may regain reduced body mass far faster than those who end traditional lifestyle regimens.

Published data in a leading health publication points out that while overweight individuals frequently drop substantial amounts of their total mass while using the jabs, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.

"People buying such drugs must be aware of the potential of rapid rebound weight gain when the therapy ends," warns lead investigator Dr. Susan Jebb.

This pace of recovery suggests a reversion to pre-treatment mass in about a year and a half.

Weighing Therapies

The study, which reviewed dozens of studies involving over 9,000 of participants, contrasted the results of GLP-1 agonists with older methods.

The team point out that individuals who lose weight through dieting usually see a less rapid weight regain—perhaps 0.1 kg a month—after stopping.

Explaining the Quick Rebound

Doctors believe the mode of action of the drugs accounts for the amplified rebound.

GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.

"Artificially providing GLP-1 concentrations several times higher than normal might result in the body to produce less of its own natural GLP-1, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher.

"Stopping of this medication results in hunger is unsuppressed, making binge eating a significant risk."

A Chronic Condition?

The NHS recommend the jabs for people with weight-linked health risks, alongside prescribed lifestyle changes.

A number of clinicians say that, considering the high risk of relapse, the therapy is often ongoing.

This view is reinforced by pharmaceutical companies, who say that the findings "emphasize the persistent character of obesity," comparing it to managing conditions like diabetes.

Patient Testimonies

Individuals who have stopped the medication report a intense resurgence of appetite.

"I experienced a trigger that goes on and I was suddenly ravenous," described a patient.

This difficulty is worsened if patients have not developed lasting lifestyle or habit modifications during therapy.

Widespread Use

Recent estimates indicate that a significant number of people in the UK have used these injections in the past year, with desire continuing to grow.

• Use is more common among females than males.
• The middle-aged demographic shows the highest usage rates.
• A large proportion obtain the drugs through private healthcare rather than the NHS.

In conclusion, clinicians emphasize that while the jabs are powerful tools for shedding pounds, they are not a permanent cure and lasting health benefits relies on combined lifestyle support.